1. Add the LINE friend
2. Send your linking code
Copy your linking code and send it on the Taiwan stocks - Winvest LINE channel
Wait for LINE to confirm that linking is complete
WELGENE 6661
Close
16
▲ 0.05 (+0.31%)
Four-Light Health Check
Overall score
36/ 100
- 📈 Fundamentals 🔴 Weak Same as yesterday
- 👁 Flows 🟡 Neutral Same as yesterday
- 📊 Technicals 🟡 Neutral Same as yesterday
- 💰 Valuation 🟡 Neutral Same as yesterday
💡 Worth noting today
No new light or technical changes today. Scroll down for the full four-light check and technical indicators.
VIP full research — unlimited tickers
Free reports today
of viewed today
This symbol is unlocked and counted toward today's quota
Reading on will use 1 of today's free views ( remaining)
Today's free views are used up; the allowance resets tomorrow
WELGENE (6661) Four-Light Health Check
Loading…
Health check data is being prepared. Please check back later.
The health check data format is being updated. Please check back later.
Weighting：📈 Fundamentals %｜👁 Flows %｜📊 Technical %｜💰 Valuation %
WELGENE (6661)
Overall health score / 100
💡 In one line: ()
Four-light detail
- 📈 Fundamentals -
- VIP
-
-
｜
- 👁 Flows -
- VIP
-
-
｜
- 📊 Technicals -
- VIP
-
-
｜
- 💰 Valuation -
- VIP
-
-
｜
The underlying four-light factors are VIP content
VIP shows the actual value, rule and note of every factor, with no daily limit.
VIP full research — unlimited tickers
Free reports today
of viewed today
This symbol is unlocked and counted toward today's quota
Reading on will use 1 of today's free views ( remaining)
Today's free views are used up; the allowance resets tomorrow
VIP unlocks
- Unlimited access to the factors and rules behind every stock/ETF four-light health check
- P/E and P/B valuation river charts
- Full sector health rankings and relative positioning
- Post-close LINE alerts for your watchlist
Data as of: ｜This site is not a licensed securities investment consultancy. The four lights are a statistical summary of public information and do not constitute investment advice.
WELGENE (6661) End-of-day prices
-
Open
-
High
-
Low
-
Close
-
Change
-
Volume
-
Prev close
WELGENE (6661) Technical indicators
WELGENE (6661) today sits below the 5-, 20- and 60-day averages in a bearish alignment. The MACD histogram stays negative and is widening, KD is 24 and leans bearish, RSI is 44 with soft short-term momentum.
Signals today
- ● Bearish moving-average alignment (close < 5-day < 20-day < 60-day)
- ● MACD keeps a negative histogram
Indicator values
| Item | Value |
|---|---|
| Close | 16.00 |
| 5-day MA | 16.14 |
| 20-day (monthly) MA | 16.49 |
| 60-day (quarterly) MA | 17.17 |
| 120-day (half-yearly) MA | 17.47 |
| 240-day (yearly) MA | 22.81 |
| K (9) | 23.58 |
| D (9) | 28.06 |
| RSI (14) | 43.51 |
| Bollinger upper band (20) | 17.37 |
| Bollinger lower band (20) | 15.61 |
| DIF (12,26) | -0.28 |
| MACD (9) | -0.25 |
| OSC histogram | -0.03 |
| Volume (lots) | 5 |
| 20-day avg. volume (lots) | 6 |
| Volume ratio (volume ÷ 20-day avg.) | 0.83 |
Indicator
WELGENE (6661) — what it does
WELGENE (6661) full name: WELGENE, in the 生技醫療業 sector, with paid-in capital of 2.33 億 and a market cap of 3.73 億.
Founded on 2003/01/30, listed on the TPEx on 2021/01/27,
its principal business is 生物醫學研究服務及相關產品銷售，暨基因檢測服務、生殖醫學類基因檢測:羊水晶片,胚胎晶片,非侵入性胎兒染色體檢測、基因定序或晶片類臨床試驗及科學研究.
| Company | WELGENE Website | ||
|---|---|---|---|
| Chairman | 陳貴弘 | President | 林怡杏 |
| Founded | 2003/01/30 | TPEx listing date | 2021/01/27 |
| Industry | 生技醫療業 | Business tax ID | 80158777 |
| Address | 台北市南港區園區街3號12樓 | ||
| Main business | 生物醫學研究服務及相關產品銷售，暨基因檢測服務、生殖醫學類基因檢測:羊水晶片,胚胎晶片,非侵入性胎兒染色體檢測、基因定序或晶片類臨床試驗及科學研究 | ||
| Paid-in capital | 2.33 億 | ||
|---|---|---|---|
| Ordinary shares issued | 2,330.42 萬 shares | ||
| Market cap | 3.73 億 (2026/09/24) | ||
| Preferred shares | 0 shares | ||
| Auditor | 勤業眾信聯合會計師事務所 | ||
| Transfer agent | 兆豐證券股務代理部 | ||
WELGENE (6661) Monthly revenue
Latest revenue for 8/2026 was NT$32.26M, MoM -2.7%, YoY -31.25%.Cumulative revenue through 8/2026 was NT$256.40M, cumulative YoY +3.23%.
Full-year 2025 revenue was NT$375.65M.
| Month | Close | Revenue (NT$M) | MoM change | YoY change | YTD vs. same period last year |
|---|---|---|---|---|---|
| Month | Close | Revenue (NT$M) | MoM change | YoY change | YTD vs. same period last year |
Latest revenue note:
A professional algo-trading development team at your service
WELGENE (6661) EPS
Latest EPS for Q2 2026 was NT$-0.07, QoQ +74%, YoY -250%.Cumulative EPS through Q2 2026 was NT$-0.34, YoY +55%.
Full-year 2025 EPS was NT$0.06.
Income statement
| Year / quarter | Close | Revenue (NT$M) | Gross profit | Operating income | Net income | EPS |
|---|
WELGENE (6661) Profitability
ROE / ROA (%)
| Year / quarter | Close | Quarterly ROE | Trailing 4Q ROE | Quarterly ROA | Trailing 4Q ROA |
|---|
sector ranking
| Ticker | Health score | Close | Change | Volume | Turnover (100M) |
|---|---|---|---|---|---|
|
() (this stock) |
WELGENE (6661) Dividend policy
The latest ex-dividend date was 2023/03/16, distribution No.1 of 2023, paying a cash dividend of NT$0.181, a cash yield of 0.81%.Over the past five years the average cash dividend was NT$0.13, for an average cash yield of 0.63%.
| Year | Ex-date | Price before ex-date | Cash dividend | Payment date | Cash yield | Stock dividend |
|---|---|---|---|---|---|---|
WELGENE (6661) Institutional flows, margin & short
| Date | Foreign | Inv. Trust | Dealer | Total |
|---|---|---|---|---|
| Date | Margin balance (lots) | Short balance (lots) | Short/margin ratio (%) |
|---|---|---|---|
WELGENE (6661) — is it a buy?
P/E river chart
The P/E river chart is a valuation tool best suited to companies with stable earnings.Rising river: earnings power is steadily improving.
Flat river: earnings power is relatively stable.
Falling river: earnings power is deteriorating.
The chart splits P/E into three bands: red, yellow and blue.
The company generated no earnings over the past year, so the P/E ratio is not a suitable way to value this stock
The P/E river chart is VIP content
Unlock to see the last 5 years of the P/E river chart
VIP full research — unlimited tickers
Free reports today
of viewed today
This symbol is unlocked and counted toward today's quota
Reading on will use 1 of today's free views ( remaining)
Today's free views are used up; the allowance resets tomorrow
VIP unlocks
- Unlimited access to the factors and rules behind every stock/ETF four-light health check
- P/E and P/B valuation river charts
- Full sector health rankings and relative positioning
- Post-close LINE alerts for your watchlist
P/B river chart
The P/B river chart is a valuation tool best suited to companies with unstable earnings, such as cyclicals.Rising river: book value is steadily improving.
Flat river: book value is relatively stable.
Falling river: book value is deteriorating.
The chart splits P/B into three bands: red, yellow and blue.
Based on the latest book value, the current price sits in the blue band, meaning the share price is at a relatively low level.
The P/B river chart is VIP content
Unlock to see the last 5 years of the P/B river chart
VIP full research — unlimited tickers
Free reports today
of viewed today
This symbol is unlocked and counted toward today's quota
Reading on will use 1 of today's free views ( remaining)
Today's free views are used up; the allowance resets tomorrow
VIP unlocks
- Unlimited access to the factors and rules behind every stock/ETF four-light health check
- P/E and P/B valuation river charts
- Full sector health rankings and relative positioning
- Post-close LINE alerts for your watchlist
Recommended brokerage accounts
如果想要開戶，目前新光證券的開戶好禮最多，新戶贈送證券期貨手續費折抵金 3000 元
也可以參考 Win投資證券開戶彙整 ，有更簡潔完善的資訊分享，包含特色、開戶禮等。
| 名稱 | 台股手續費 | 新戶禮 |
| 新光證券 (開戶點我) | 手續費 0 元 每月電子下單 100 萬以內 |
|
| 國泰證券 (開戶點我) | 最低手續費 1 元 | 完成體驗登記+首筆成交回饋 300 元7-11數位商品卡券 2026/1/1~2026/9/30 |
| 口袋證券 (開戶點我) | 優惠價查詢 | 最高 600 元 -開立台股或台+美股送 $300 手續費折抵金 -首次開立美股複委託且 30 天內美股交易一筆送 $300 超商禮券 2026/7/1~9/30 |
(資料來源：各券商，最新資訊以各券商為主。資料整理：Win 投資)
My Watchlist
Sign in to build and track your own watchlist. Once you add symbols, you get a full closing report every day: health check, technical changes and a comparison against the TAIEX.